Edition:
United Kingdom

Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

60.03USD
17 Aug 2018
Change (% chg)

$0.08 (+0.13%)
Prev Close
$59.95
Open
$60.15
Day's High
$60.85
Day's Low
$58.72
Volume
688,700
Avg. Vol
1,269,042
52-wk High
$111.36
52-wk Low
$17.52

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.58 December 18 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 5 5 5 7
(3) HOLD 2 2 2 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.82 1.82 1.82 1.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 8 26.01 35.95 20.10 42.45
Quarter Ending Dec-18 8 30.30 60.00 21.00 43.05
Year Ending Dec-18 9 1,181.49 1,222.62 1,169.49 193.20
Year Ending Dec-19 9 274.07 605.00 80.80 234.72
Earnings (per share)
Quarter Ending Sep-18 8 -0.58 -0.30 -0.73 -0.32
Quarter Ending Dec-18 8 -0.56 -0.09 -0.78 -0.33
Year Ending Dec-18 9 3.79 4.55 3.22 -1.10
Year Ending Dec-19 9 -1.60 1.05 -3.03 -0.82

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 1,033.34 1,087.72 54.38 5.26
Quarter Ending Mar-18 35.62 38.02 2.40 6.75
Quarter Ending Dec-17 36.98 95.47 58.49 158.18
Quarter Ending Sep-17 117.32 152.93 35.61 30.35
Quarter Ending Jun-17 34.23 34.59 0.36 1.05

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 26.01 38.51 53.35 53.35 42.45
Quarter Ending Dec-18 30.30 47.24 54.73 54.73 43.05
Year Ending Dec-18 1,181.49 1,204.14 1,178.83 1,178.83 193.20
Year Ending Dec-19 274.07 246.82 276.50 276.50 234.72

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 1 1 5
Quarter Ending Dec-18 0 1 1 5
Year Ending Dec-18 1 0 6 2
Year Ending Dec-19 0 0 1 1
Earnings